Bank of Montreal
ABEO icon

Bank of Montreal’s Abeona Therapeutics ABEO Stock Holding History

Bank of Montreal’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,300
Closed -$84.8K – 3496
2024
Q3 		$84.8K Buy
+14,300
New +$74.7K ﹤0.01% 3291
2021
Q2 		– Sell
-68
Closed -$3K – 3620
2021
Q1 		$3K Sell
68
-306
-82% -$16.9K ﹤0.01% 4798
2020
Q4 		$17K Buy
374
+262
+234% +$8.92K ﹤0.01% 4479
2020
Q3 		$3K Sell
112
-114
-50% -$7.19K ﹤0.01% 4561
2020
Q2 		$19K Buy
226
+163
+259% +$11.3K ﹤0.01% 3859
2020
Q1 		$3K Sell
63
-134
-68% -$8.95K ﹤0.01% 3755
2019
Q4 		$16K Buy
197
+56
+40% +$3.95K ﹤0.01% 4399
2019
Q3 		$8K Buy
141
+31
+28% +$2.32K ﹤0.01% 4472
2019
Q2 		$13K Buy
+110
New +$18.4K ﹤0.01% 4399
2019
Q1 		– Sell
-18
Closed -$3.22K – 4261
2018
Q4 		$3K Buy
18
+9
+100% +$1.96K ﹤0.01% 4217
2018
Q3 		$3K Hold
9
– – ﹤0.01% 4210
2018
Q2 		$4K Sell
9
-391
-98% -$171K ﹤0.01% 4158
2018
Q1 		$144K Sell
400
-572
-59% -$213K ﹤0.01% 2789
2017
Q4 		$385K Buy
+972
New +$402K ﹤0.01% 2399

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bank of Montreal's ABEO Position: Q4 2024 in Review

Bank of Montreal sold out of Abeona Therapeutics (ABEO) in Q4 2024, closing a stake of 14,300 shares — an estimated $84.8K sold.

Bank of Montreal first reported a position in ABEO in Q4 2017 and held it in 14 quarters. The position peaked at $385K in Q4 2017. 65 funds tracked by Wall St. Rank hold ABEO as of Q4 2024.

  • Bank of Montreal reported no remaining Abeona Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 14,300 Abeona Therapeutics shares in Q4 2024, an estimated $84.8K.
  • Bank of Montreal first reported a position in Abeona Therapeutics in Q4 2017 and held it in 14 quarters.
  • Bank of Montreal's Abeona Therapeutics position peaked at $385K in Q4 2017.
  • 65 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.